Showing results (191-200 of 231) with videos related to
Sort By:
Pageof 24
Frontiers in Neurology|July 6, 2019
Effects of Exergaming on Attentional Deficits and Dual-Tasking in Parkinson's DiseaseEva Schaeffer, Jan-Hinrich Busch, Benjamin Roeben, et al.IBRO Neuroscience Reports|November 24, 2025
Evaluation of an antibody panel for alpha-synuclein detection in FFPE rectal biopsies in Parkinson's diseaseKatja Schröder, Carmen Kintrup, Kristína Kulcsárová, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 22, 2008
Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer's disease, and other dementiasLisa Mosconi, Wai H Tsui, Karl Herholz, et al.Movement Disorders : Official Journal of the Movement Disorder Society|November 27, 2024
Environmental Risk Factors for Parkinson's Disease: A Critical Review and Policy ImplicationsKajsa Atterling Brolin, Eva Schaeffer, Ashvin Kuri, et al.Plos One|March 4, 2016
GDF15/MIC1 and MMP9 Cerebrospinal Fluid Levels in Parkinson's Disease and Lewy Body DementiaWalter Maetzler, Willy Deleersnijder, Valérie Hanssens, et al.Alzheimer'S & Dementia (New York, N. Y.)|July 14, 2025
A common outcome set for trials in dementia with Lewy bodies (DLB COS)Joseph P M Kane, Rachel L Fitzpatrick, Sara Betzhold, et al.Parkinsonism & Related Disorders|August 21, 2021
A new CERAD total score with equally weighted z-scores and additional executive and non-amnestic "CERAD-Plus" tests enhances cognitive diagnosis in patients with Parkinson's disease: Evidence from the LANDSCAPE studyRobert Lillig, Anja Ophey, Jörg B Schulz, et al.Journal of Neurology|July 1, 2024
Mid- and late-life lifestyle activities as main drivers of general and domain-specific cognitive reserve in individuals with Parkinson's disease: cross-sectional and longitudinal evidence from the LANDSCAPE studyAnja Ophey, Kathrin Wirtz, Steffen Wolfsgruber, et al.The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|August 8, 2018
Psychometric Properties of an Abbreviated Version of the Apathy Evaluation Scale for Parkinson Disease (AES-12PD)Yuliya Stankevich, Ulrike Lueken, Monika Balzer-Geldsetzer, et al.Journal of Neurology|February 5, 2021
Effects of Levodopa on quality of sleep and nocturnal movements in Parkinson's DiseaseEva Schaeffer, Thomas Vaterrodt, Laura Zaunbrecher, et al.Pageof 24